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An RNA Aptamer-Based Microcantilever Sensor To Detect the
Inflammatory Marker, Mouse Lipocalin-2
Abstract
Lipocalin-2 (Lcn2) is a biomarker for many inflammatory-based diseases, including acute kidney injury,
cardiovascular stress, diabetes, and various cancers. Inflammatory transitions occur rapidly in kidney and
cardiovascular disease, for which an in-line monitor could be beneficial. Microcantilever devices with
aptamers as recognition elements can be effective and rapidly responsive sensors. Here, we have selected and
characterized an RNA aptamer that specifically binds mouse Lcn2 (mLcn2) with a dissociation constant of
340 ± 70 nM in solution and 38 ± 22 nM when immobilized on a surface. The higher apparent affinity of the
immobilized aptamer may result from its effective multivalency that decreases the off-rate. The aptamer
competes with a catechol iron-siderophore, the natural ligand of mLcn2. This and the results of studies with
mLcn2 mutants demonstrate that the aptamer binds to the siderophore binding pocket of the protein. A
differential interferometer-based microcantilever sensor was developed with the aptamer as the recognition
element in which the differential response between two adjacent cantilevers (a sensing/reference pair) is
utilized to detect the binding between mLcn2 and the aptamer, ensuring that sensor response is independent
of environmental influences, distance between sensing surface and detector and nonspecific binding. The
system showed a detection limit of 4 nM. This novel microcantilever aptasensor has potential for development
as an in-line monitoring system for mLcn2 in studies of animal models of acute diseases such as kidney and
cardiac failure.
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ABSTRACT: Lipocalin-2 (Lcn2) is a biomarker for many inﬂammatory-based
diseases, including acute kidney injury, cardiovascular stress, diabetes, and
various cancers. Inﬂammatory transitions occur rapidly in kidney and
cardiovascular disease, for which an in-line monitor could be beneﬁcial.
Microcantilever devices with aptamers as recognition elements can be eﬀective
and rapidly responsive sensors. Here, we have selected and characterized an
RNA aptamer that speciﬁcally binds mouse Lcn2 (mLcn2) with a dissociation
constant of 340 ± 70 nM in solution and 38 ± 22 nM when immobilized on a
surface. The higher apparent aﬃnity of the immobilized aptamer may result
from its eﬀective multivalency that decreases the oﬀ-rate. The aptamer
competes with a catechol iron-siderophore, the natural ligand of mLcn2. This and the results of studies with mLcn2 mutants
demonstrate that the aptamer binds to the siderophore binding pocket of the protein. A diﬀerential interferometer-based
microcantilever sensor was developed with the aptamer as the recognition element in which the diﬀerential response between
two adjacent cantilevers (a sensing/reference pair) is utilized to detect the binding between mLcn2 and the aptamer, ensuring
that sensor response is independent of environmental inﬂuences, distance between sensing surface and detector and nonspeciﬁc
binding. The system showed a detection limit of 4 nM. This novel microcantilever aptasensor has potential for development as
an in-line monitoring system for mLcn2 in studies of animal models of acute diseases such as kidney and cardiac failure.
Lipocalin-2 (Lcn2) is a member of the lipocalin superfamily.Increased blood levels of the human Lcn2 (NGAL) are
associated with many diseases. Lcn2 is a reliable and early
indicator of acute kidney injury (AKI) and is proposed as a
promising marker for AKI diagnosis and prognosis based on a
meta-data analysis from clinical studies involving 19 countries
and 2538 patients.1 For monitoring acute inﬂammatory
responses such as acute kidney injury that can occur during
medical intervention, in-line monitors are most eﬀective.
Currently Lcn2 is detected by antibody-based immunoassays,
which are not readily incorporated into in-line detection
systems, in part due to the instability of antibodies to repeated
use at room temperature. Nucleic acids are more stable to
temperature ﬂuctuations and aptamers can be used repeatedly
for real-time detection. To date, many aptamers have been
selected against a broad range of targets with binding aﬃnities
comparable to monoclonal antibodies and have been
incorporated into many sensor platforms.2
Here, we describe the selection of an RNA aptamer that
speciﬁcally recognizes mouse lipocalin-2 (mLcn2) but neither
the human ortholog (NGAL) nor the chicken siderophore
binding lipocalin (Ex-FABP). The aptamer binding site includes
the conserved iron-siderophore binding pocket of mLcn2. The
mLcn2 aptamer was incorporated into a microcantilever system
and demonstrated to be capable of selectively detecting mLcn2
in a homogeneous assay. The diﬀerential microcantilever sensor
utilized two adjacent microcantilevers (a sensing/reference
pair) to determine the mechanical deﬂection induced because
of speciﬁc binding between the surface-immobilized aptamer
and mLcn2. To ensure that sensor response was due to speciﬁc
binding, only the sensing cantilever was functionalized with the
aptamer and a novel diﬀerential interferometer was utilized to
determine the relative deﬂection between the sensing and
reference cantilevers. The results of these studies suggest that a
microcantilever−aptamer detection system might be developed
for in-line detection of mLcn2 in studies of animal models of
critical human diseases.
■ MATERIALS AND METHODS
Reagents. The reagents used in these studies were: T4
polynucleotide kinase and RNase I (Promega), RNase T1 and
DNase I (Epicenter), RNase V1, ThermoScript reverse
transcriptase and TOPO XL PCR cloning kit (Life
Technologies), Taq DNA polymerase (GenScript), enter-
okinase (EMD Chemicals), recombinant T7 RNA polymerase
(prepared in the laboratory), dNTP and NTP (Thermo Fisher
Scientiﬁc, Inc.), γ-32P-ATP, and α-32P-ATP (MP Biomedicals),
55FeCl3 (Perkin−Elmer), 2,3-dihydroxybenzoic acid (DHBA;
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Sigma−Aldrich), TALON metal aﬃnity resin (Clontech),
superﬂow Ni-NTA resin (Qiagen), and other chemicals
(Sigma−Aldrich).
All oligonucleotides (see Table S1 in the Supporting
Information) were chemically synthesized with standard
desalting by either the DNA Facility (Iowa State University)
or Integrated DNA Technology (IDT). The 5′-thiolated
oligonucleotides were synthesized with high-performance liquid
chromatography (HPLC) puriﬁcation by IDT.
Recombinant Proteins. The glycosylated 10xHis-mLcn2
protein, expressed by murine myeloma cell line NS0, was
purchased from R&D Systems, Inc. Recombinant 6xHis-tagged
wild-type mLcn2 and its mutants, human Lcn2 (hLcn2) and
chicken counterpart (Ex-FABP), were expressed in E. coli and
puriﬁed as previously described.3 To remove the 6xHis tags, the
recombinant fusion proteins were incubated with enterokinase
in the buﬀer containing 20 mM Tris, 50 mM NaCl, 2 mM
CaCl2, pH 7.4 at room temperature for 24 h. The uncut
proteins and His tag were removed by capture on Nickel-NTA
resin. Successful cleavage was conﬁrmed by SDS-polyacryla-
mide gel electrophoresis.
In Vitro Selection of Aptamers. In vitro selection of an
aptamer for mLcn2 was carried out by SELEX (Systematic
Evolution of Ligands by EXponential enrichment).4 Prior to the
ﬁrst round of selection, a dsDNA pool was generated from a
ssDNA library (oligo487) by primer extension. Reverse
transcribed polymerase chain reaction (RT-PCR) ampliﬁcation
was used to generate DNA for subsequent selection rounds. A
random RNA oligonucleotide pool was generated by in vitro
transcription, using the dsDNA as template, during certain
rounds of SELEX, α-32P-ATP was incorporated into the
transcripts to monitor the percentage of the aptamers binding
to mLcn2. For each positive selection, the RNA pool was
incubated with mLcn2-Talon, the nonbinding RNAs were
removed by washing, then the mLcn2-bound RNAs were eluted
from the resin with 150 mM imidazole, pH 7.4. The latter
RNAs were reverse-transcribed and then PCR-ampliﬁed to
generate the enriched pool for the next round of selection. In
addition to 10 rounds of positive selection against mLcn2-
Talon, negative selections were performed prior to rounds 3, 6,
and 9. For each negative selection, the RNA pool was incubated
with Talon resin and the nonbinding RNAs were removed by
washing to provide the sample that was mixed with mLcn2-
resin for the following positive selection. The enriched pool
from the 10th SELEX round was cloned into the TOPO XL
PCR cloning plasmid for sequencing.
Binding Aﬃnity Measurement. A standard ﬁlter binding
assay was used to determine the dissociation constant (Kd) and










where B is percentage bound of a ligand, Bmin the minimal
percentage bound of a ligand, Bmax the maximal percentage
bound of a ligand, and [M] the ligand concentration.
Isothermal titration calorimetry (ITC) was also used to
measure the Kd value and thermodynamics of the aptamer−
mLcn2 interaction at room temperature in the presence of 50
mM Tris, 150 mM NaCl, 5 mM MgCl2, pH 7.4.
RNase Sensitivity Analysis. 5′-end labeling of RNAs with
32P was carried out at 37 °C for 1.5 h in a 20 μL mixture of 70
mM Tris (pH 7.6 at 25 °C), 10 mM MgCl2, 5 mM DTT, 1U/
μL T4 polynucleotide kinase and 2 μCi/μL γ-32P-ATP (6000
Ci/mmol). The labeled RNAs were puriﬁed by electrophoresis
through an 8% polyacrylamide gel containing 7 M urea. The
32P-labeled aptamer (2.5 nM) with varying concentrations of
mLcn2 or hLcn2 in 10 μL of reaction buﬀer (50 mM KH2PO4,
150 mM NaCl, 5 mM MgCl2, pH 7.4) were incubated at 23 °C
for 10 min with RNase I (5 × 10−4 U/μL) or RNase V1 (1 ×
10−5 U/μL). Partial alkaline hydrolysis was done in 50 μM
Na2CO3, pH 9.0 at 95 °C for 5 min. RNase T1 digestion of the
labeled aptamer was carried out in a 10-μL reaction mixture
containing 0.5−1 U/μL RNase T1, 5 M urea, 350 mM sodium
citrate, 0.7 mM EDTA, pH 5.0, at 50 °C for 4 min and the
reaction was stopped by the addition of loading buﬀer to ﬁnal
concentrations of 47.5% formamide, 0.05% Bromophenol Blue,
and 0.05% xylene cyanol FF. Samples were analyzed, after
separation by electrophoresis through a 10% denaturing
polyacrylamide gel containing 7 M urea, with a Typhoon
8600 Variable Model Imager (GE Healthcare).
Microcantilever Detection Assay. A diﬀerential micro-
cantilever sensor was utilized to determine the mechanical
deformation associated with aptamer−ligand binding. The
sensor consisted of two microcantilevers (a sensing/reference
pair), where only the sensing cantilever was functionalized with
the aptamer. A novel diﬀerential interferometer (Figure 1) was
used to measure the diﬀerential displacement of the sensing
cantilever, with respect to the reference cantilever. A laser beam
was split into two parallel beams with mutually orthogonal
polarizations, using a calcite-crystal-based beam displacer. The
resulting two beams were focused on the ends of the cantilever
pairs and reﬂected beams were recombined into a single beam
with the beam displacer (Figure 1). As a result, the recombined
beam is an elliptically polarized beam whose two linear
components have a path length diﬀerence equal to twice the
diﬀerential displacement (Δl) between the cantilevers. The
elliptically polarized beam was passed through a suitably
oriented Wollaston prism in order to interfere the two linear
components. The intensity of the interfered signal was
measured to determine the path length diﬀerence between
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Figure 1. Schematic representation of the sensing strategy for mLcn2
detection and optical circuit of diﬀerential surface stress sensor. Laser
wavelength is 635 nm. A pair of microlens arrays with lenses 240 and
900 μm in diameter, with pitches of 250 μm and 1 mm, respectively,
were used to direct the beams toward the sensing/reference pair.
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where Is (Ip) is the light intensity of the reﬂected beams and θ is
the phase diﬀerence between the reﬂected beams (θ = 4π(Δl/λ,
where λ is the wavelength of the laser beam). The change of the
phase diﬀerence between the linear components was monitored
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The diﬀerential displacement was utilized to determine the
diﬀerential surface stress between the sensing and reference




















where E is the elastic modulus, ν the Poisson’s ratio, L the
length of the cantilevers, and t the thickness of the cantilevers.
Measurement of diﬀerential surface stress ensures that the
detected signal is proportional to the speciﬁc binding of ligand
with aptamer on the sensing cantilever and eliminates the
inﬂuence of environmental disturbances such as nonspeciﬁc
binding, changes in pH, ionic strength, and especially the
temperature.
In the current study, the sample cantilever was coated with
5′-thiolated oligo569, while the reference cantilever was coated
with an irrelevant thiolated DNA oligonucleotide (see Table S1
in the Supporting Information). After coating, sensing and
Figure 2. Selection of mLcn2 aptamers. (A) Enrichment of the mLcn2 binding RNAs during the progress of in vitro selection was monitored as the
binding percentage of the RNA pool in the presence (+) and absence (−) of mLcn2 using the ﬁlter binding assay. (B) After the 10th round of
SELEX, the RNAs were cloned and sequenced. Twenty one (21) diﬀerent sequences were obtained from 56 clones. Sequence alignment using
AlignX (VectorNTI, Invitrogen) showed that 2 of the 21 sequences (A1, A4) accounted for 25% and 21% of the population, respectively. Each
sequence is denoted by a capital letter followed by Arabic numbers. The frequency of each sequence is shown at the right side of the dendrogram.
(C) The secondary structures of the two dominant sequences, A1 and A4, were predicted by S-fold. The common structural element between these
two candidates was identiﬁed as a three-way junction (in rectangle). Truncations of the original full length candidates were made based on this three-
way junction.
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reference cantilevers were further incubated in 3 mM solution
of 6-mercapto-1-hexanol for 1 h to displace any physisorbed
sequences and to ﬁll the unoccupied gold bonding sites
between the immobilized receptor molecules. The diﬀerential
surface stress changes were plotted against the protein
concentrations, and the Kd value was calculated by the
nonlinear ﬁtting curve with the same equation as that used
for Kd determination in the ﬁlter binding assay, with the Bmax
and Bmin representing maximal and minimal surface stress
changes, respectively. The limit of detection (LOD) was
derived from the lowest measured signal (XL), using the
nonlinear ﬁtting equation, with XL= Xbl + 3Sbl for which Xbl is
the mean of the blank measurement and Sbl is the standard
deviation of the blank measurement.6
■ RESULTS
Selection of mLcn2 Aptamers. The SELEX procedure
was performed for 10 rounds, after which the mLcn2 bound
RNA was found to have been enriched to 18%, from the
starting 0.4%, bound to the protein (see Figure 2A). Among the
56 cloned RNAs from the 10th round, 21 aptamer candidates
were identiﬁed by sequence alignment with two sequences (A1
and A4) dominating (Figure 2B). Both sequences were
predicted to fold in a three-way junction (Figure 2C) and the
truncated three-way junction of A1 (oligo569), which had the
best aﬃnity for mLcn2 (see Figure S1 in the Supporting
Information), was further characterized.
Binding Aﬃnity and Stoichiometry of the mLcn2
Aptamer. By ﬁlter binding and isothermal titration calorimetry
(ITC) dissociation constants of 340 ± 83 nM and 210 ± 42
Figure 3. Speciﬁcity and aﬃnity of the mLcn2 aptamer. (A) Lcn2 from mouse (mLcn2) was titrated against Oligo569 to determine the Kd value in
more than 10 independent ﬁlter binding assays using diﬀerent batches of 6xHis-mLcn2 fusion protein and oligo569. One representative dataset with
a nonlinear ﬁtting curve is shown. The binding of oligo569 to hLcn2 and Ex-FABP was determined with 3 independent ﬁlter binding assays. No
detectable binding was observed for these two mutants up to 10 μM protein. For each ﬁlter binding assay, duplicates were performed to obtain the
standard deviation within each assay. (B) The mLcn2 aptamer (oligo569) binds to recombinant bacterial nonglycosylated mLcn2 lacking a (●) His-
tag and (○) glycosylated His-tagged mLcn2 expressed by mammalian cells. Solid line represents the nonlinear ﬁtting curve for mLcn2 with no His-
tag, and the dotted line represents the nonlinear ﬁtting curve for the glycosylated 10xHis-mLcn2. One representative result from two independent
experiments is shown for each protein. (C) The mLcn2 aptamer (oligo569) was titrated into 5 μM 6xHis-mLcn2 by ITC. The integrated area under
each heat-release peak (⧫) from each injection was plotted against the molar ratio of aptamer to mLcn2, and the curve was ﬁtted with a one-site
independent binding model (solid line). The ﬁrst titration data point (broken circle) was omitted from the analysis. One representative result from
two independent experiments is shown.
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nM (mean ± standard deviation (SD)) were respectively
determined for the binding of oligo569 to mLcn2 (see Figure
3), and the stoichiometry was 0.87 ± 0.035 (Figure 3C). The
same stoichiometry was obtained by gel ﬁltration (see Figure S3
in the Supporting Information).
Figure 4. Identiﬁcation of binding sites on the mLcn2 aptamer. (A) RNase sensitivity analysis of the mLcn2 aptamer. 2.5 nM 5′ 32P-labeled oligo569
was incubated with or without 4 μM hLcn2 or mLcn2 at (0.3 and 3 μM) and subjected to digestion by RNase I (left panel) and RNase V1 (right
panel). Control channels include: OH, partial alkaline hydrolysis of the aptamer; G, G ladder of the aptamer generated by partial RNase T1
digestion; −, aptamer alone with no treatment. The ﬁgure shows the results of one of at least four independent experiments. (B) Predicted secondary
structure of the mLcn2 aptamer. A consensus structure from MC-Fold and S-Fold predictions includes a summary of the results for protection from
cleavage by RNase I (▽) and RNase V1 (▼). Lines between the residues indicate base-pairing predicted as dynamic (dotted lines) or stable (solid
lines). Possible secondary structural elements are shown in rectangles with labels. (C) Eﬀect of variations in aptamer sequence on binding activity. A
schematic representation of the mLcn2 aptamer shows the eﬀect of varying its sequence (see Table S1 in the Supporting Information) on the aﬃnity
for mLcn2. The box with dashed-line border indicates a deletion and the boxes with solid line borders indicate substitutions. Oligonucleotide
numbers are shown followed by the fold change in Kd (mean ± standard deviation (SD)), in comparison to oligo569 (average from 2−3
independent experiments). (Note that the abbreviation “nb” means no binding (Kd could not be estimated due to a lack of saturable binding by 20
μM protein.)
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The eﬀect of the His tag and mLcn2 glycosylation on its
interaction with the aptamer was determined by the ﬁlter
binding assay. The Kd values for oligo569 binding mLcn2
without the His tag and the His-tagged glycosylated mLcn2
were 430 ± 94 nM and 380 ± 220 nM, respectively (see Figure
3B). Thus, oligo569 (aka mLcn2 aptamer) binds mLcn2 with
submicromolar aﬃnity in a manner that is aﬀected by neither
glycosylation nor the His tag.
Binding Sites and Secondary Structure of the mLcn2
Aptamer. The binding sites for mLcn2 on the aptamer were
determined by RNase sensitivity analysis with hLcn2 as a
negative control for mLcn2 (see Figure 4A). Nucleotides
including A11−U17, A25−A28, and U32 were protected from
the RNase I digestion and nucleotides including C20−G21 and
U32−C33 were protected from RNase VI digestion when the
aptamer was bound to mLcn2. Based on the RNase sensitivity
analysis and predicted secondary structures (see Figure S4 in
the Supporting Information), the most probably secondary
structure of oligo569 is a three-way junction with the two loops
and stem 2 involved in binding to mLcn2 (Figure 4B), which is
also the most stable predicted structure. Stem 1 probably has
no direct contact with mLcn2 but may stabilize the three-way
junction structure.
To further conﬁrm the proposed secondary structure and
binding interactions, sequence variants of the aptamers were
synthesized (see Table S1 in the Supporting Information) and
tested for their aﬃnities to mLcn2 (see Figure 4C). Deletion or
substitution of the nucleosides on the two loops (oligos 572,
573, 577, 579, and 580) either abolished or dramatically
decreased the aptamer binding aﬃnity to mLcn2 (Figure 4C).
By contrast, the shuﬄing of stem 2 (oligo578) did not change
the binding aﬃnity and addition of G·C pairs to the stem 1
(oligo571, oligo576) slightly increased the binding aﬃnity.
These aﬃnity changes are not likely due to changes in overall
secondary structure of the variants as the secondary structures
predicted for these aptamer variants retained the three-way
junction of the parent sequence, except that the short G·C stem
near loop 1 was lost in the predicted secondary structure of
oligo573, because of deletion of the CCG residues (see Figure
S5 in the Supporting Information). Taken together, these
results identify the key residues on the mLcn2 aptamer
contributing to high aﬃnity binding with mLcn2, as those in
loops 1 (A11−U17) and 2 (A25−G29).
Identiﬁcation of Binding Sites of the Aptamer on
Mouse Lipocalin-2. None of the substitutions of the charged
and polar surface amino acids with alanine aﬀected the
interaction of mLcn2 and aptamer. The diﬀerences in Kd
were less than 4-fold for any of these substitution mutants,
compared with the wild-type (WT) protein (Table 1). Larger
eﬀects on binding were observed with alanine substitutions in
the calyx (see Figure 5A and Table 1). The three calyx alanine
substitutions were shown via circular dichroism (CD) to have
little overall eﬀect on mLcn2 structure (see Figure S6 in the
Supporting Information), which is a conclusion supported by a
crystallography study of hLcn2 with double mutations that
included Arg103 in hLcn2.7 In addition, the calyx mutants were
evaluated for structural integrity by gel ﬁltration and native
polyacrylamide gel electrophoresis (see Figure S7 and Table S2
in the Supporting Information). These results show that,
although there are diﬀerences between the mutants and WT
proteins in the gel ﬁltration elution proﬁles and in their rates of
travel on electrophoresis, the diﬀerences are small and do not
correlate with the ability of the aptamer to bind the protein.
Therefore, we conclude that the mutant protein structures are
homogeneous and approximate that of the WT protein.
The three basic calyx-exposed residues bound by the aptamer
are also essential for the iron−siderophore binding to hLcn2,8
which we conﬁrm for mLcn2 (Figure 5B). Although the Kd
values for binding to the double and triple calyx mutants are
decreased, compared to the WT and single calyx mutant, all
titrations reached stoichiometric binding. Bovine serum
albumin (BSA), when used in place of mLcn2, showed little
binding of Fe(DHBA)3 at saturating Fe(DHBA)3 concen-
trations, thus ruling out the possibility that the observed
stoichiometric binding of the double and triple mutants was
due to nonspeciﬁc binding (see Figure S8 in the Supporting
Information). Therefore, in addition to demonstrating that the
calyx mutants bind Fe(DHBA)3 more poorly than the WT,
these results also support the conclusion that these mutants are
structurally similar to the WT mLcn2. To determine if the
aptamer binds mLcn2 by way of the siderophore or to the same
amino acid residues as the siderophore, we tested for
competition or cooperation between the aptamer and Fe-
(DHBA)3 for binding mLcn2 and found that they compete (see
Figures 5C and 5D). The competition is speciﬁc to the aptamer
with no competition with Fe(DHBA)3 for binding mLcn2 by
an irrelevant RNA oligonucleotide (oligo258). This suggests
that (i) the aptamer binding surface includes the same three
basic residues in the mLcn2 calyx that form the siderophore
binding site and (ii) the aptamer recognizes properly folded
mLcn2.
Detection of mLcn2 Using an Aptamer-Coated Micro-
cantilever. We have previously demonstrated that ﬁber-optic-
based microcantilever sensors detect cocaine in a conﬁguration
with the cocaine aptamer linked to the cantilever.9 Thiol-
modiﬁed mLcn2 aptamer and an irrelevant oligonucleotide (see
Table S1 in the Supporting Information) were coated on
sensing and reference microcantilevers, respectively. Upon the
Table 1. Eﬀect of Alanine Replacements of mLcn2 Residues
on Aptamer Bindinga
mutated amino acids
Kd (mean ± SD,
μM) mutation location
mLcn2 0.34 ± 0.073 wild-type
S23A_N26A 0.65 ± 0.28 surface
D41A 1.1 ± 0.16 surface
D45A_Q46A 1.1 ± 0.24 surface
T65A_E66A 0.76 ± 0.10 surface
H120A 0.72 ± 0.15 surface
R176A_K179A 0.67 ± 0.10 surface
E80A_N81A_N82A 1.5 ± 0.46 surface
E150A_N151A 0.92 ± 0.61 surface
E169A_E172A 0.82 ± 0.26 surface
D195A_Q196A_D199A 1.7 ± 0.39 surface
R103A 2.0 ± 0.75 iron−siderophore binding
sites
R103A_K147A NBb iron−siderophore binding
sites
R103A_K147A_K156A NBb iron−siderophore binding
sites
aTen (10) surface areas containing charged or polar amino acids were
predicted by the homologous modeling of mLcn2 using crystallog-
raphy data from human lipocalin-2 and later conﬁrmed by the reported
mLcn2 crystal structure.14 All the tests were repeated at least four
t ime s . Th e b i nd i n g a s s a y s o f R103A_K147A and
R103A_K147A_K156A were repeated six times. bNB = no binding.
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addition of analytes (mLcn2 or the R103A_K147A double
mutant mLcn2), the diﬀerential surface stress between these
two cantilevers was recorded to measure the binding using eq 3.
The binding aﬃnity was estimated by nonlinear curve ﬁtting of
the plot of surface stress versus concentration (Figure 6). In
this context, the aptamer aﬃnity for mLcn2 was determined to
be 38 ± 22 nM. This value is signiﬁcantly lower than that
measured for the aptamer in solution and may be due to
aptamer crowding on the cantilever surface with a resulting
decrease in apparent koff. By ﬁtting the experimental data using
a nonlinear ﬁtting equation, 7 mN/m was determined as the
sensitivity of the surface stress measurements, and the limit of
detection (LOD) for the mLcn2 concentration was estimated
to be 4 nM. The microcantilever gave no signiﬁcant response to
the R103A_K147A mutant of mLcn2 (Figure 6) that does not
bind the aptamer (Figure 5A).
■ DISCUSSION
Here, we describe the successful selection of an RNA aptamer
that speciﬁcally recognizes mLcn2 with an aﬃnity of 200−300
nM. Interestingly, when on the microcantilever, this aptamer
has a 10-fold higher aﬃnity, which could be due to a decrease in
the dissociation rate of the protein from the cantilever surface
on which the aptamers are highly concentrated. A concentrated
surface of aptamers would increase the probability of a
dissociated protein rebinding to another aptamer, compared
to when both aptamer and protein are in solution. The tight
molecular packing on the cantilever surface may also stabilize
the aptamer structure and thereby decrease the proportion of
the aptamer population that adopts alternate nonbinding
structures.
With the current aptamer, the diﬀerential interferometry-
based microcantilever deﬂection measurement allows us to
detect concentrations as low as 4 nM (96 ng/mL) mLcn2. This
is less sensitive than the currently available ELISA assay (LOD
= 0.2 nM; R&D). However, the reported range of mLcn2 in
blood ranges from 100 ng/mL (basal) to 3000 ng/mL
(inﬂamed condition),10 which is within the range of detection
by aptamer-functionalized microcantilevers.
A common feature of aptamers is their exceedingly high
speciﬁcity for the analyte against which they were selected.
Consistent with this general observation, the aptamer is highly
speciﬁc for the mLcn2 calyx, even though the same trilogy of
amino acids is present in the same positions in the hLcn2 calyx.
Sequence alignment showed that, in addition to the three iron−
siderophore binding amino acids, other amino acids forming
the iron−siderophore binding pockets are conserved for both
human and mouse lipocalin-2 (see Figure S9 in the Supporting
Information).11 The fact that mutation of the three conserved
amino acids completely eliminates binding of the aptamer to
mLcn2 suggests that (i) these three amino acids form the major
interaction sites of the aptamer on mLcn2 and (ii) the
diﬀerence in the interaction of the aptamer with the human and
mouse proteins may be because the aptamer binds to another,
as yet unidentiﬁed, region on mLcn2 that is diﬀerent in the
Figure 5. Identiﬁcation of binding sites on mLcn2. (A) Alanine
substitutions in the calyx decrease the aﬃnity of the RNA aptamer for
mLcn2. The nonlinear ﬁtting curves are shown by the solid and dotted
lines for (●) mLcn2 and (○) R103A, respectively, while the double
mutants (△) and triple mutants (▲) showed no binding. One
representative result is shown from at least four independent
experiments for each protein. (B) Alanine substitutions in the
mLcn2 calyx decrease iron−siderophore binding. Recombinant
mLcn2 proteins with combinations of alanine substitutions of the
amino acids Arg 103, Lys147, Lys156 were titrated against 100 nM
55Fe(DHBA)3 ((●) mLcn2, (○) R103A, (△) R103A_K147A, and
(▲) R103A_K147A_K156A). The ﬁgure shows one representative
data point from at least four repeats. (C) mLcn2 aptamers compete
with Fe(DHBA)3 for binding to mLcn2. The fractional binding of
55Fe-(DHBA)3 (100 nM) bound to mLcn2 (200 nM) in the presence
of various concentrations of each oligonucleotide is shown. The
resulting IC50 values were 11 ± 2.0 μM (Ki at 2.9 ± 0.50 μM) and 5.5
± 0.70 μM (Ki at 1.5 ± 0.20 μM) for oligo569 and oligo576,
respectively. (D) Fe(DHBA)3 competes with mLcn2 aptamers for
binding to mLcn2. The fractional binding of 32P-aptamers (2 nM
oligo569 or oligo576) bound to mLcn2 (4 μM) in the presence of
varying Fe(DHBA)3.
Figure 6. Surface stress values as a function of protein concentrations.
Nonlinear ﬁtting curve (solid line) was calculated from the averaged
values of (●) six independent assays for mLcn2 or (○) two
independent assays for mLcn2 (R103A_K147A). The two dotted lines
below and above the ﬁtting curve for mLcn2 represent the 95%
conﬁdential interval. The estimated Kd value for mLcn2 is 38 ± 22
nM.
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human Lcn2 or may be due to a dynamic aspect of their
structures that is not evident in the X-ray crystallographic data.
Surface stress measurements associated with speciﬁc binding
clearly demonstrate the unique advantages of the diﬀerential
interferometry-based microcantilever sensor. In other state-of-
the-art microcantilever-based sensors,12 the surface stress
changes are determined through optical deﬂectometry and
the measurement resolution depends on the distance between
the optical detector and the cantilever. In addition, measure-
ments by single cantilever sensors12b,c are inﬂuenced by
nonspeciﬁc binding and environmental disturbances such as
temperature ﬂuctuations and hydrodynamic eﬀects. Measure-
ment of the diﬀerential bending of the sensing cantilever, with
respect to a reference cantilever, ensures that the sensor
response is independent of environmental disturbances. The
sensitivity of sensor measurement does not depend on the
distance between the sensing surface and the detector. As a
result, the surface stress sensor is amenable to miniaturization
and can also include an array of sensors and be integrated with
other systems on a single microelectromechanical systems
device.
In conclusion, we have selected an RNA aptamer that
speciﬁcally binds mLcn2 with an aﬃnity of 210 nM in solution
and 38 nM when immobilized. The RNA−protein interaction
involves bases on the aptamer loop regions and the iron−
siderophore binding amino acid trilogy in the calyx of the
protein molecule. The aptamer is speciﬁc for the mouse over
the human protein, despite the identity of amino acids to which
the aptamers binds in the calyx. We have shown the potential of
this aptamer as a detection probe on a microcantilever platform.
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